Literature DB >> 23012122

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Evaluation and interpretation of screening outcomes.

S Moss1, R Ancelle-Park, H Brenner.   

Abstract

Multidisciplinary, evidence-based guidelines for quality assurance in colorectal cancer screening and diagnosis have been developed by experts in a project coordinated by the International Agency for Research on Cancer. The full guideline document covers the entire process of population-based screening. It consists of 10 chapters and over 250 recommendations, graded according to the strength of the recommendation and the supporting evidence. The 450-page guidelines and the extensive evidence base have been published by the European Commission. The chapter on evaluation and interpretation of screening outcomes includes 20 graded recommendations. The content of the chapter is presented here to promote international discussion and collaboration by making the principles and standards recommended in the new EU Guidelines known to a wider professional and scientific community. Following these recommendations has the potential to enhance the control of colorectal cancer through improvement in the quality and effectiveness of the screening process, including multi-disciplinary diagnosis and management of the disease. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 23012122     DOI: 10.1055/s-0032-1309788

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  20 in total

1.  European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication.

Authors:  L von Karsa; J Patnick; N Segnan; W Atkin; S Halloran; I Lansdorp-Vogelaar; N Malila; S Minozzi; S Moss; P Quirke; R J Steele; M Vieth; L Aabakken; L Altenhofen; R Ancelle-Park; N Antoljak; A Anttila; P Armaroli; S Arrossi; J Austoker; R Banzi; C Bellisario; J Blom; H Brenner; M Bretthauer; M Camargo Cancela; G Costamagna; J Cuzick; M Dai; J Daniel; E Dekker; N Delicata; S Ducarroz; H Erfkamp; J A Espinàs; J Faivre; L Faulds Wood; A Flugelman; S Frkovic-Grazio; B Geller; L Giordano; G Grazzini; J Green; C Hamashima; C Herrmann; P Hewitson; G Hoff; I Holten; R Jover; M F Kaminski; E J Kuipers; J Kurtinaitis; R Lambert; G Launoy; W Lee; R Leicester; M Leja; D Lieberman; T Lignini; E Lucas; E Lynge; S Mádai; J Marinho; J Maučec Zakotnik; G Minoli; C Monk; A Morais; R Muwonge; M Nadel; L Neamtiu; M Peris Tuser; M Pignone; C Pox; M Primic-Zakelj; J Psaila; L Rabeneck; D Ransohoff; M Rasmussen; J Regula; J Ren; G Rennert; J Rey; R H Riddell; M Risio; V Rodrigues; H Saito; C Sauvaget; A Scharpantgen; W Schmiegel; C Senore; M Siddiqi; D Sighoko; R Smith; S Smith; S Suchanek; E Suonio; W Tong; S Törnberg; E Van Cutsem; L Vignatelli; P Villain; L Voti; H Watanabe; J Watson; S Winawer; G Young; V Zaksas; M Zappa; R Valori
Journal:  Endoscopy       Date:  2012-12-04       Impact factor: 10.093

2.  Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.

Authors:  William E Barlow; Elisabeth F Beaber; Berta M Geller; Aruna Kamineni; Yingye Zheng; Jennifer S Haas; Chun R Chao; Carolyn M Rutter; Ann G Zauber; Brian L Sprague; Ethan A Halm; Donald L Weaver; Jessica Chubak; V Paul Doria-Rose; Sarah Kobrin; Tracy Onega; Virginia P Quinn; Marilyn M Schapira; Anna N A Tosteson; Douglas A Corley; Celette Sugg Skinner; Mitchell D Schnall; Katrina Armstrong; Cosette M Wheeler; Michael J Silverberg; Bijal A Balasubramanian; Chyke A Doubeni; Dale McLerran; Jasmin A Tiro
Journal:  J Natl Cancer Inst       Date:  2020-03-01       Impact factor: 13.506

3.  Colon Cancer Screening Programs: Impact of an Organized Screening Strategy Assessed by the EDIFICE Surveys.

Authors:  Jérôme Viguier; Jean-François Morère; Lysel Brignoli-Guibaudet; Christine Lhomel; Sébastien Couraud; François Eisinger
Journal:  Curr Oncol Rep       Date:  2018-03-05       Impact factor: 5.075

4.  Case fatality rate of the adult in-patients with COVID-19 and digestive system tumors: A systematic review and meta-analysis.

Authors:  Guoqun Wang; Lanlan Pan; Jianyi Zhao; Jie Tang; Yueyu Fang; Hui Sun; Poshita Kumari Seesaha; Wensen Chen; Xiaofeng Chen
Journal:  Medicine (Baltimore)       Date:  2022-06-24       Impact factor: 1.817

5.  Risk and Characteristics of Postcolonoscopy Interval Colorectal Cancer after a Positive Fecal Test: A Nationwide Population-Based Study in Korea.

Authors:  Chang Kyun Lee; Kui Son Choi; Chang Soo Eun; Dong-Il Park; Dong Soo Han; Minjoo Yoon; Mina Suh; Jae Kwan Jun
Journal:  Cancer Res Treat       Date:  2017-02-24       Impact factor: 4.679

6.  Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe.

Authors:  Esther Toes-Zoutendijk; Isabel Portillo; Sarah Hoeck; Isabel de Brabander; Philippe Perrin; Catherine Dubois; Monique van Leerdam; Iris Lansdorp-Vogelaar; Marc Bardou
Journal:  J Med Screen       Date:  2019-10-23       Impact factor: 2.136

7.  The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.

Authors:  Arthur I Kooyker; Esther Toes-Zoutendijk; Annemieke W J Opstal-van Winden; Manon C W Spaander; Maaike Buskermolen; Hanneke J van Vuuren; Ernst J Kuipers; Folkert J van Kemenade; Chris Ramakers; Maarten G J Thomeer; Evelien Dekker; Iris D Nagtegaal; Harry J de Koning; Monique E van Leerdam; Iris Lansdorp-Vogelaar
Journal:  Int J Cancer       Date:  2020-01-09       Impact factor: 7.396

8.  The impact of COVID-19 pandemic in the colorectal cancer prevention.

Authors:  Giovanna Del Vecchio Blanco; Emma Calabrese; Livia Biancone; Giovanni Monteleone; Omero Alessandro Paoluzi
Journal:  Int J Colorectal Dis       Date:  2020-06-04       Impact factor: 2.571

9.  Increase in the Colorectal Cancer Screening Rate by a Round-Mailed Fecal Immunochemical Testing Kit and Associated Factors in Underserved Regions of Korea: A Community-Based Intervention Study.

Authors:  Seri Hong; Hye Young Shin; Bomyee Lee; Na Rae Hwang; Sang-Hyun Hwang; Jae Kwan Jun
Journal:  Gut Liver       Date:  2020-05-15       Impact factor: 4.519

10.  Overview on Patient Centricity in Cancer Care.

Authors:  Šarunas Narbutas; Kristina York; Barry D Stein; Kara Magsanoc-Alikpala; Yoshiyuki Majima; Zoltan Kalo; Timea Almasi; Andras Inotai
Journal:  Front Pharmacol       Date:  2017-10-05       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.